Our data suggest that high glucose consumption and increased LDH activity foster immunosuppression and reduced ICI efficacy in MM patients, as recently observed in an anti-PD-1 + anti-LAG-3 retrospective study (27). This evidence concerns the gene LAG3 and Miyoshi myopathy.